Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | EXL01 |
Trade Name | |
Synonyms | F. prausnitzii strain EXL01 |
Drug Descriptions |
EXL01 is a strain of Faecalibacterium prausnitzii, which may enhance antitumor immune response (PMID: 38957477). |
DrugClasses | Microbiome 7 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + Bevacizumab + EXL01 | Atezolizumab Bevacizumab EXL01 | 0 | 1 |
EXL01 | EXL01 | 0 | 0 |
EXL01 + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin | EXL01 Fluorouracil Leucovorin Nivolumab Oxaliplatin | 0 | 1 |
EXL01 + unspecified PD-L1 antibody | EXL01 unspecified PD-L1 antibody | 0 | 0 |